Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Buy AEX Gold Inc. NPV (DI) (AEXG) by Tom Winnifrith in ShareProphets
- Long Term Buy Spectra Systems Corporation (SPSY) by Royston Wild in The Motley Fool
- Long Term Buy Strix Group (KETL) by Royston Wild in The Motley Fool
- Long Term Buy Wynnstay Group (WYN) by Royston Wild in The Motley Fool
- Long Term Buy GlaxoSmithKline (GSK) by G A Chester in The Motley Fool
- Long Term Buy Sage Group (SGE) by G A Chester in The Motley Fool
- Long Term Buy Diageo (DGE) by G A Chester in The Motley Fool
- Buy Tesco (TSCO) by Alan Oscroft in The Motley Fool
- Strong Buy OptiBiotix Health (OPTI) by Tom Winnifrith in ShareProphets
- Sell Versarien (VRS) by Tom Winnifrith in ShareProphets
- Buy British American Tobacco (BATS) by Roland Head in The Motley Fool
- Buy BP (BP.) by Roland Head in The Motley Fool
- Buy Phoenix Group Holdings (PHNX) by Roland Head in The Motley Fool
- Long Term Buy Carr's Group (CARR) by Royston Wild in The Motley Fool
- Long Term Buy Target Healthcare Reit Ltd (THRL) by Royston Wild in The Motley Fool
- Buy London Stock Exchange Group (LSE) by Anna Sokolidou in The Motley Fool
- Buy Begbies Traynor Group (BEG) by Royston Wild in The Motley Fool
- Buy Codemasters Group Holdings (CDM) by Royston Wild in The Motley Fool
- Long Term Buy M&G (MNG) by Rupert Hargreaves in The Motley Fool
- Long Term Buy Melrose Industries (MRO) by Rupert Hargreaves in The Motley Fool
Dechra Pharmaceuticals (DPH)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Dechra Pharmaceuticals Overview
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.Latest Dechra Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Royston Wild | – | 2020-09-20 09:55:00 20/09/2020 | – |
| – | Liberum Capital | – | 2020-09-11 08:10:00 11/09/2020 | – |
| – | Kevin Godbold | – | 2020-09-08 08:10:00 08/09/2020 | – |
| – | RBC Capital | – | 2020-09-07 12:05:00 07/09/2020 | – |
| – | Liberum Capital | – | 2020-08-24 08:40:00 24/08/2020 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Dechra Pharmaceuticals Overview
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.Latest Dechra Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Royston Wild | – | 2020-09-20 09:55:00 20/09/2020 | – |
| – | Liberum Capital | – | 2020-09-11 08:10:00 11/09/2020 | – |
| – | Kevin Godbold | – | 2020-09-08 08:10:00 08/09/2020 | – |
| – | RBC Capital | – | 2020-09-07 12:05:00 07/09/2020 | – |
| – | Liberum Capital | – | 2020-08-24 08:40:00 24/08/2020 | – |